- NEWS
Omicron is supercharging the COVID vaccine booster debate
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-021-03592-2
References
Patalon, T. et al. JAMA Intern. Med. https://doi.org/10.1001/jamainternmed.2021.7382 (2021).
Bar-On, Y. M. et al. N. Engl. J. Med. 385, 1393–1400 (2021).
Barda, N. et al. Lancet https://doi.org/10.1016/S0140-6736(21)02249-2 (2021).
Andrews, N. et al. Preprint at medRxiv https://doi.org/10.1101/2021.11.15.21266341 (2021).
Gardner, B. J. & Kilpatrick, A. M. Preprint at medRxiv https://www.medrxiv.org/content/10.1101/2021.10.25.21265500 (2021).
Keeling, M. J. et al. Preprint at medRxiv https://www.medrxiv.org/content/10.1101/2021.11.05.21265977 (2021).
Stein, F. Global. Health 17, 112 (2021).